Infiltrative Lymphoma-Associated Bradycardia and Cardiac Conduction Abnormalities

Pritha Subramanyam; Syed S Mahmood; William Dinsfriend; Raymond D Pastore; Peter Martin; Angel T Chan; Jonathan W Weinsaft; Jim W Cheung

doi:10.1016/j.jaccao.2020.01.002

Infiltrative Lymphoma-Associated Bradycardia and Cardiac Conduction Abnormalities

JACC CardioOncol. 2020 Mar 17;2(1):135-138. doi: 10.1016/j.jaccao.2020.01.002. eCollection 2020 Mar.

Authors

Pritha Subramanyam¹, Syed S Mahmood¹, William Dinsfriend², Raymond D Pastore³, Peter Martin³, Angel T Chan², Jonathan W Weinsaft¹, Jim W Cheung¹

Affiliations

¹ Department of Medicine, Division of Cardiology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York, USA.
² Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
³ Department of Medicine, Division of Hematology and Oncology, Weill-Cornell Medicine, New York-Presbyterian Hospital, New York, New York, USA.

No abstract available

Keywords: ABVD, adriamycin, bleomycin, vinblastine, dacarbazine; CMR, cardiac magnetic resonance; ECG, electrocardiography; EF, ejection fraction; FDG, fluorodeoxyglucose; LGE, late gadolinium enhancement; PET-CT, positron emission tomography-computed tomography; R-EPOCH, ritixubimab, etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin; TTE, transthoracic echocardiography; TVP, transvenous pacemaker; bradycardia; cardiac magnetic resonance; cardiac masses; conduction disease; lymphoma; pacemaker.

Publication types

Review

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States